ComplianceESGJune 02, 2021

How a large pharmaceutical firm improved ESG through a single platform

Leading companies have realized that it’s not enough to merely have a good EHS policy. What’s also needed is a standardized approach to global EHS strategy with integrated technologies to gain valuable insight into EHS and sustainability (EHS&S) performance. Having up-to-date data at the ready from an integrated system enables organizations to take advantage of opportunities for improvement and meet corporate EHS&S goals.

In 2015, the company started a phased module-by-module implementation of the Enablon platform, starting with Metrics Management. From 2016 to 2017, they further transitioned legacy systems into the Enablon platform, including Event Management, Action Plans, Self-Assessments, and Compliance Management. The company released their first public position statements on environment and safety, and by 2018 achieved four out of five environmental goals ahead of the due date. By 2019, they moved their enterprise risk management to the Enablon platform and in 2020 they released a new set of EHS&S commitments and KPIs.

The company is continuing their collaboration with Enablon to help them achieve targets, meet corporate goals, and continually improve their EHS performance. Learn more in the full case study! Learn more in the full case study!

The Company

The company profiled in this case study is a global leader in the pharmaceutical industry that develops and manufactures affordable, high-quality generic and specialty drugs in over 60 markets, serving over 200 million worldwide every day. They are dedicated to improving the lives of patients across the globe with their impressive portfolio of over 3,500 products, the largest of any pharmaceutical company in the world.

Explore related topics
Back To Top